A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

NCT00002084 ·Status: COMPLETED ·Phase: NA

Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix

NCT00946556 ·Status: COMPLETED ·Phase: NA

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

NCT00158860 ·Status: COMPLETED ·Phase: PHASE4

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

NCT00860977 ·Status: COMPLETED ·Phase: PHASE3

Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding

NCT00803543 ·Status: COMPLETED ·Phase: NA

Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?

NCT01176409 ·Status: COMPLETED ·Phase: PHASE3

A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons

NCT00161434 ·Status: COMPLETED ·Phase: PHASE4

The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children

NCT00001054 ·Status: WITHDRAWN ·Phase: PHASE1

Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)

NCT01453075 ·Status: COMPLETED ·Phase: PHASE1

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

NCT01059084 ·Status: WITHDRAWN ·Phase: NA

Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

NCT01390805 ·Status: COMPLETED

Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes

NCT01658826 ·Status: TERMINATED ·Phase: PHASE2

Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients

NCT00477334 ·Status: COMPLETED ·Phase: PHASE4

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV

NCT00527618 ·Status: COMPLETED ·Phase: PHASE4

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

NCT00362297 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes

NCT00306787 ·Status: COMPLETED ·Phase: PHASE3

Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

NCT01346475 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2

NCT01047540 ·Status: COMPLETED ·Phase: PHASE2

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

NCT00486200 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes

NCT00171990 ·Status: COMPLETED ·Phase: PHASE3

A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

NCT00076232 ·Status: COMPLETED ·Phase: PHASE3

Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir

NCT00031486 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood

NCT00001115 ·Status: COMPLETED ·Phase: NA

A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients

NCT00001038 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes

NCT01765114 ·Status: TERMINATED ·Phase: PHASE2